Speciality Medicines Limited (BOM:544738)
India · Delayed Price · Currency is INR 184.00
+4.00 (2.22%)
At close: Jul 9, 2026
Speciality Medicines Revenue
In the fiscal year ending March 31, 2026, Speciality Medicines had annual revenue of 752.85M INR with 29.20% growth.
Revenue
752.85M
Revenue Growth
+29.20%
P/S Ratio
2.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.61B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 752.85M | 170.14M | 29.20% |
| Mar 31, 2025 | 582.71M | 307.47M | 111.71% |
| Mar 31, 2024 | 275.25M | 42.84M | 18.43% |
| Mar 31, 2023 | 232.41M | -172.03M | -42.54% |
| Mar 31, 2022 | 404.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.34B |
| Bal Pharma | 3.12B |
| Parnax Lab | 2.49B |
| Sat Kartar Life | 2.01B |
| Lactose (India) | 1.63B |
| Aayush Wellness | 1.55B |
| Oxygenta Pharmaceutical | 1.13B |
| Accretion Pharmaceuticals | 898.18M |